Testing the Effect of Adding Chronic Azithromycin to Inhaled Tobramycin

Clinical Trial

Offered by: Nemours
Location: Orlando, Fla.

Trial Name

Testing the Effect of Adding Chronic Azithromycin to Inhaled Tobramycin 

What is the trial about?

The purpose of the TEACH study is to see how azithromycin and inhaled tobramycin work together to treat cystic fibrosis patients with chronic Pseudomonas aeruginosa infection. We want to find out if azithromycin reduces the benefit of inhaled tobramycin or not.

Who can participate?

People who are ages 12 to 17 with cystic fibrosis, which have had Pseudomonas aeruginosa in the last year and have taken inhaled tobramycin in the last six months.

What is involved?

If you agree to take part in the study, your child will come to Nemours for a total of three study visits over six weeks. If your child completes all three study visits he/she will have the option to continue in an extension portion of the study for another eight weeks. The extension part of the study will not have a placebo group; everyone will be on azithromycin.

Pulmonary function tests, electrocardiogram, sputum collection.

Contact Nemours Clinical Trials

Trial Name:

Testing the Effect of Adding Chronic Azithromycin to Inhaled Tobramycin 

Contact Information

(800) 354-5690
ClinicalTrials@nemours.org